Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
And always best to let others know how much in profit yiu are;imagine how much he/she was in profit when the SP was 15 (and didn't sell one share) !!!!
Depends on what you estimate the takeover price to be lol
A lot higher than the share price now.
If Hemo got bought out what could that potentially equate to share price wise.
1, I said the move with the price of share options was a brilliant move if it was to boost SP in anticipation of news, I also said if not it was a really pointless exercise in giving away 100k that he didnt have too. I had hoped Vlad had discovered his inner business guru, but apparently still just a brilliant scientist :P
2, GlobalCo, I posted the evidence, many many people reviewed and agreed, links to actual publications that bore striking similarity, that said when Eli was announced I was first on here to hold my hands up and admit I was wrong and delete my tweets, its called owning my mistakes, something i wish alot more people would do, I have little hope for you with this regard.
3, If I thought there was risk of failure I would de-risk, I am probably about 100k in profit with hemo at the moment, I could sell and go for a free ride IF I thought necessary, simply I dont, the market fluctuations to date have been nothing to do with Hemogenyx published results and all to do with trader and market sentiment.
But like you say, I am invested to the hilt (Well I was, I have been working though lock down so bank is alot healthier now, comfortable again). With > 200k invested in Hemogenyx I genuinely would look at any evidence or proof that you could provide that would indicate this is not a safe investment. I absolutely would react and de-risk if faced with facts that led me to believe that my money is at risk. I am not an idiot, I will look at both sides of an argument and am not here for a fight.
Eli Lilly will not walk away from CDX without a good reason. To have allowed the name drop so close to the end of pre-clinicals means they're pretty happy with the results. The chances of the small remaining works between name drop and start September being a deal breaker is extremely low.
There's so way to know for sure but all the signs of a deal are there.
John, be serious, every RNS or public statement to date has strongly favoured Eli signing the licencing agreement. All updates have been worded to imply that it is very likely the licence will be signed. So yes there is very strong indication that they will sign, its available in public records so its not an opinion.
In terms of NOT signing, which I said is a possibility, albeit far fetched IMO, I said SP would very likely fall in response as would be expected. HOWEVER if you refer to the numerous RNS Hemo have demonstrated that CDX works in vivo and in vitro, basically everything except for human trials. Human trials will not start without the support of a global pharma it is just too expensive for Hemo to go alone. Basically failure at this juncture is not going to happen. Eli Lilly stuck with Hemo to this point AFTER proving it works in a lab so to walk away would be bonkers but its not impossible, they could run into any number of problems their end and just not be able to sign such as not being able to agree terms, issues over brexit and investing in a UK company, blocked by some stupid Trump sanction, some other far fetched and unforseen reason. I DONT KNOW why they would not sign, point it is possible.
Does not change the fact, Hemo have an mCap of < 50mil
Eli have paid for the testing and proved that CDX works in a lab, put their name to it, took an extension, Vlad is VERY positive about them in tweets.
Either they sign and its $$$
OR
They dont sign and its still $$$, not signing does not invalidate CDX, it does not say oh all those tests suddenly are invalid. On what planet would another pharma NOT want to snap it and/or Hemo up?
Oooooh Swimmy you're about to get spanked by JHFH!
*Grabs Popcorn*
Small holder 5000 shares ...want news expected ... tomorrow is Friday ... will it be the drums
I don’t want to be out of it over the weekend .... boom time
Not me only looking over past board and comments
By the way 2pm has past wake up USA
Best of luck to all holders
Very useful and concise summary - thanks JustHereForHemo.
Eli have given us no indication that they dont want to licence or any sort of indication of concern, infact they have only increased their co-operation with hemo in recent years.
I am hopeful that the 3 months had atleast 1month or more buffer built in so we wont have very long to wait atall but at the same time I would get very excited if they didnt sign. CDX is one of the bigger product lines Hemo are working on and the first refusal of global exclusive licence to Eli Lilly basically takes it off the table to every other Global Pharma and makes Hemo less attractive as a take over to them. Eli walk away having basically rubber stamped our CDX, proved it works in vivo and in vitro etc then suddenly you have a VERY attractive proposition for basically any other Pharma to walk in and either just licence OR what I would do is move aggressively for take over, very had with so many shares not in public hands but seriously mCap is <50mil. If you have the choice between licencing and potentially paying 100s of mill or even billions over the coming years in royalties to Hemogenyx OR just offer like 10* the mCap to investors and get the entire package and everything else thats going for like 500mil what would you do?
Basically CDX failure at this point looks to be off the table, VERY unlikely to fail before Phase 2 or 3 and even then unlikely. The market is BILLIONS. Eli have put their name to Hemogenyx, they have invested their time and money proving it works. Hemo mCap is pocket change, they know they either sign the licencing agreement and get a massive discount, take over Hemogenyx or they lose their competitive advantage that they have right now.
For us investors, in terms of Eli and the CDX licencing agreement there is no downside here, the SP might dip if no licencing agreement is forthcoming but rest assured it wont last long.
Indeed the wait can be frustrating at times, and when you are feeling like that it's best to take a step back and go over your research notes.
Hemo has shown amazing strength this week where many other shares have been decimated by the uncertainty within the market.
Just hold on in there, news is nigh!
Thanks both - I am a holder in HEMO but just frustrated with expected timing of news.
To answer your question, this lse board holds close to 11% of shares in this company (if everyone is being honest) and that's only the disclosed amount. We are pretty confident about announcing a licensing agreement. We can never be sure though so only invest what you feel comfortable with. Gl
90% sure from me, but the question is when?
Deadline is December 1st
Hi all - how confident are we on the licensing agreement will definitely be signed with Eli?
All the best.